Literature DB >> 28710643

[Vesicoureteral reflux : Watchful waiting, surgery or antibiotic prophylaxis?]

A Schröder1.   

Abstract

Primary vesicoureteral reflux (VUR) is a dynamic disease with several factors influencing its course. Therapeutic options range from watchful waiting to open surgery. Multiple risk factors for the development of pyelonephritis are identified, which then determine the decision for the appropriate treatment option. They include age, gender, history of pyelonephritis and renal scarring, bladder and bowel dysfunction (BBD), circumcision status and parental preference. The use of continuous antibiotic prophylaxis (CAP) is becoming increasingly controversial with antibiotic resistance being a major concern. Aggressive treatment of BBD and infant circumcision can greatly reduce the risk for pyelonephritis and should always be considered and discussed. This article is soley concerned with primary VUR.

Entities:  

Keywords:  Bladder bowel dysfunction; Pyelonephritis; Renal scarring; Surgical reflux correction; Urinary tract infection

Mesh:

Year:  2017        PMID: 28710643     DOI: 10.1007/s00120-017-0453-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  20 in total

1.  Urine culture from bag specimens in young children: are the risks too high?

Authors:  F Al-Orifi; D McGillivray; S Tange; M S Kramer
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder.

Authors:  Evann E Hilt; Kathleen McKinley; Meghan M Pearce; Amy B Rosenfeld; Michael J Zilliox; Elizabeth R Mueller; Linda Brubaker; Xiaowu Gai; Alan J Wolfe; Paul C Schreckenberger
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

Review 3.  Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis.

Authors:  Myrto Eleni Flokas; Marios Detsis; Michail Alevizakos; Eleftherios Mylonakis
Journal:  J Infect       Date:  2016-07-28       Impact factor: 6.072

4.  The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux.

Authors:  Per Brandström; Ulf Jodal; Ulla Sillén; Sverker Hansson
Journal:  J Pediatr Urol       Date:  2011-07-31       Impact factor: 1.830

Review 5.  May we go on with antibacterial prophylaxis for urinary tract infections?

Authors:  R Beetz
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

Review 6.  Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates/Infants With Prenatal Hydronephrosis.

Authors:  Steven J Skoog; Craig A Peters; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

7.  Voiding dysfunction after bilateral extravesical ureteral reimplantation.

Authors:  B A Lipski; M E Mitchell; M W Burns
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

Review 8.  Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies.

Authors:  D Singh-Grewal; J Macdessi; J Craig
Journal:  Arch Dis Child       Date:  2005-05-12       Impact factor: 3.791

9.  The Swedish reflux trial in children: IV. Renal damage.

Authors:  Per Brandström; Tryggve Nevéus; Rune Sixt; Eira Stokland; Ulf Jodal; Sverker Hansson
Journal:  J Urol       Date:  2010-05-23       Impact factor: 7.450

Review 10.  Routine neonatal circumcision for the prevention of urinary tract infections in infancy.

Authors:  Vanitha A Jagannath; Zbys Fedorowicz; Vikas Sud; Abhishek Kumar Verma; Sakineh Hajebrahimi
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.